Featured Research

from universities, journals, and other organizations

Possible new treatment strategies for pancreatic cancer

Date:
March 4, 2011
Source:
University of Georgia
Summary:
Researchers have identified a protein that can be modified to improve the effectiveness of one of the most common drugs used to treat pancreatic cancer.

New University of Georgia research has identified a protein that can be modified to improve the effectiveness of one of the most common drugs used to treat pancreatic cancer.

The research, published in the March edition of the journal Cancer Research, found that a cell-surface protein called CNT1, which transports cancer-killing drugs into tumor cells, was reduced in function in two thirds of pancreatic tumors. By improving the function of CNT1, the researchers increased the effectiveness of the cancer-killing drugs in pancreatic tumor cells derived from human patients, said lead-author Raj Govindarajan, assistant professor of pharmaceutical and biomedical sciences in the UGA College of Pharmacy.

"The transporter was failing to take up the drug, so there were a bunch of different drug-resistant tumor cells," said Govindarajan. "Therapies that restore CNT1 could increase the effectiveness of the drug by helping carry the drug into the cell."

The drug most commonly used to treat pancreatic cancer is called gemcitabine and works by entering into the DNA of cancer cells and stopping replication. Many pancreatic tumor cells are resistant to gemcitabine, which makes the disease very difficult to treat, explained Govindarajan.

The researchers identified different methods to enhance CNT1 function and slow growth of the tumor cells. They found that by using additional drugs that inhibit pathways that degrade CNT1, they could partially restore its normal function and transport more gemcitabine into the tumor cells to prevent proliferation of the tumor.

The researchers attained the same results by genetically augmenting CNT1. "We over-expressed this protein in tumor cells so that it is functional continuously throughout the cell cycle, and it took up a lot of the drug and facilitated tumor killing," said Govindarajan. "So it shows potential for therapeutic aspects."

Govindarajan and his colleagues also found that CNT1 was likely regulated by tiny RNA molecules called micro-RNAs. "Micro-RNAs are clearly emerging as a new paradigm in gene regulation," said Govindarajan. "We could potentially use micro-RNAs to increase CNT1 expression and increase tumor-cell targeting of gemcitabine."

The American Cancer Society estimates that 43,000 people will be diagnosed with pancreatic cancer every year, and about 85 percent of those will die within one year of diagnosis.

Govindarajan said that the findings need to be evaluated in laboratory animals for both effectiveness and toxicity aspects to determine if they are feasible therapeutic options. He hopes that future studies will confirm the possibilities of combining additional therapies with gemcitabine to more effectively treat pancreatic cancer. "What we are trying to do is see if we can improve the standard of care for treating pancreatic cancer," he said.

The study was funded by the National Cancer Institute and by the department of pharmaceutical and biomedical sciences at the University of Georgia.


Story Source:

The above story is based on materials provided by University of Georgia. The original article was written by Kirk McAlpin. Note: Materials may be edited for content and length.


Journal Reference:

  1. Y. D. Bhutia, S. W. Hung, B. Patel, D. Lovin, R. Govindarajan. CNT1 Expression Influences Proliferation and Chemosensitivity in Drug-Resistant Pancreatic Cancer Cells. Cancer Research, 2011; DOI: 10.1158/0008-5472.CAN-10-2736

Cite This Page:

University of Georgia. "Possible new treatment strategies for pancreatic cancer." ScienceDaily. ScienceDaily, 4 March 2011. <www.sciencedaily.com/releases/2011/03/110303163330.htm>.
University of Georgia. (2011, March 4). Possible new treatment strategies for pancreatic cancer. ScienceDaily. Retrieved April 17, 2014 from www.sciencedaily.com/releases/2011/03/110303163330.htm
University of Georgia. "Possible new treatment strategies for pancreatic cancer." ScienceDaily. www.sciencedaily.com/releases/2011/03/110303163330.htm (accessed April 17, 2014).

Share This



More Health & Medicine News

Thursday, April 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Thousands Of Vials Of SARS Virus Go Missing

Thousands Of Vials Of SARS Virus Go Missing

Newsy (Apr. 16, 2014) A research institute in Paris somehow misplaced more than 2,000 vials of the deadly SARS virus. Video provided by Newsy
Powered by NewsLook.com
Formerly Conjoined Twins Released From Dallas Hospital

Formerly Conjoined Twins Released From Dallas Hospital

Newsy (Apr. 16, 2014) Conjoined twins Emmett and Owen Ezell were separated by doctors in August. Now, nearly nine months later, they're being released from the hospital. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins